1. Home
  2. NWL vs CRSP Comparison

NWL vs CRSP Comparison

Compare NWL & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWL
  • CRSP
  • Stock Information
  • Founded
  • NWL 1903
  • CRSP 2013
  • Country
  • NWL United States
  • CRSP Switzerland
  • Employees
  • NWL N/A
  • CRSP N/A
  • Industry
  • NWL Plastic Products
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NWL Industrials
  • CRSP Health Care
  • Exchange
  • NWL Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • NWL 3.6B
  • CRSP 3.5B
  • IPO Year
  • NWL N/A
  • CRSP 2016
  • Fundamental
  • Price
  • NWL $10.02
  • CRSP $40.48
  • Analyst Decision
  • NWL Buy
  • CRSP Buy
  • Analyst Count
  • NWL 11
  • CRSP 18
  • Target Price
  • NWL $10.00
  • CRSP $76.60
  • AVG Volume (30 Days)
  • NWL 6.3M
  • CRSP 1.9M
  • Earning Date
  • NWL 02-07-2025
  • CRSP 11-05-2024
  • Dividend Yield
  • NWL 2.79%
  • CRSP N/A
  • EPS Growth
  • NWL N/A
  • CRSP N/A
  • EPS
  • NWL N/A
  • CRSP N/A
  • Revenue
  • NWL $7,709,000,000.00
  • CRSP $202,829,000.00
  • Revenue This Year
  • NWL N/A
  • CRSP N/A
  • Revenue Next Year
  • NWL $0.23
  • CRSP $758.18
  • P/E Ratio
  • NWL N/A
  • CRSP N/A
  • Revenue Growth
  • NWL N/A
  • CRSP 19.31
  • 52 Week Low
  • NWL $5.39
  • CRSP $39.41
  • 52 Week High
  • NWL $11.78
  • CRSP $91.10
  • Technical
  • Relative Strength Index (RSI)
  • NWL 50.28
  • CRSP 31.88
  • Support Level
  • NWL $9.74
  • CRSP $42.86
  • Resistance Level
  • NWL $11.78
  • CRSP $44.99
  • Average True Range (ATR)
  • NWL 0.46
  • CRSP 2.39
  • MACD
  • NWL -0.15
  • CRSP -1.11
  • Stochastic Oscillator
  • NWL 22.81
  • CRSP 2.58

About NWL Newell Brands Inc.

Newell Brands Inc is an American global consumer goods company. The business activities of the group function through three segments namely, Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The learning and Development segment generates revenue for the firm which offers baby gear and infant care products; writing instruments, including markers and highlighters, pens, and pencils; art products; activity-based adhesive and cutting products, and labeling solutions.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: